Cargando…
Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Netherlands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763517/ https://www.ncbi.nlm.nih.gov/pubmed/35997953 http://dx.doi.org/10.1007/s44228-022-00016-4 |
| _version_ | 1784853079184637952 |
|---|---|
| author | Khan, Shamis Alam, Sara Taveras Ramos, Rosa Torres Mbue, John Etumbani Apostolidou, Effrosyni Rivero, Gustavo A. Yellapragada, Sarvari Venkata |
| author_facet | Khan, Shamis Alam, Sara Taveras Ramos, Rosa Torres Mbue, John Etumbani Apostolidou, Effrosyni Rivero, Gustavo A. Yellapragada, Sarvari Venkata |
| author_sort | Khan, Shamis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9763517 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Netherlands |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97635172023-01-04 Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series Khan, Shamis Alam, Sara Taveras Ramos, Rosa Torres Mbue, John Etumbani Apostolidou, Effrosyni Rivero, Gustavo A. Yellapragada, Sarvari Venkata Clin Hematol Int Correspondence Springer Netherlands 2022-08-23 /pmc/articles/PMC9763517/ /pubmed/35997953 http://dx.doi.org/10.1007/s44228-022-00016-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Khan, Shamis Alam, Sara Taveras Ramos, Rosa Torres Mbue, John Etumbani Apostolidou, Effrosyni Rivero, Gustavo A. Yellapragada, Sarvari Venkata Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title | Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title_full | Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title_fullStr | Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title_full_unstemmed | Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title_short | Luspatercept in Low-Risk Myelodysplastic Syndrome: A Real-World Single Institution Case Series |
| title_sort | luspatercept in low-risk myelodysplastic syndrome: a real-world single institution case series |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763517/ https://www.ncbi.nlm.nih.gov/pubmed/35997953 http://dx.doi.org/10.1007/s44228-022-00016-4 |
| work_keys_str_mv | AT khanshamis luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT alamsarataveras luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT ramosrosatorres luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT mbuejohnetumbani luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT apostolidoueffrosyni luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT riverogustavoa luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries AT yellapragadasarvarivenkata luspaterceptinlowriskmyelodysplasticsyndromearealworldsingleinstitutioncaseseries |